Immunization and the millennium development goals: Progress and challenges in Latin America and the Caribbean

Health Affairs

Volumn 27, Issue 2, 2008, Pages 487-493

  Andrus, Jon Kim ^a   Crouch, Alan Arthur ^a   Fitzsimmons, John ^a   Vicari, Andrea ^a   Tambini, Gina ^b  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b PAHO ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTRAL AMERICA; CHILDHOOD MORTALITY; CONTROLLED STUDY; HEALTH CARE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; PREVENTIVE HEALTH SERVICE; SOUTH AND CENTRAL AMERICA;

CARIBBEAN REGION; DEVELOPING COUNTRIES; FEMALE; HEALTH POLICY; HEALTH PRIORITIES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; LATIN AMERICA; MALE; MEASLES; ORGANIZATIONAL OBJECTIVES; TETANUS; WHOOPING COUGH;

EID: 41749090473     PISSN: 02782715     EISSN: 02782715     Source Type: Journal    
DOI: 10.1377/hlthaff.27.2.487     Document Type: Article

References (38)

1. United Nations Development Program, Human Development Report 2003 - Millennium Development Goals: A Compact Among Nations to End Human Poverty (Oxford, England: Oxford University Press, 2003);
2. and J. Bryce et al. "Countdown to 2015: Tracking Intervention Coverage for Child Survival," Lancet 368, no. 9541 (2006): 1067-1076.
3. J. Andrus et al., "Introduction of New and Underutilized Vaccines: Perspectives from the Americas," in Recent Advances in Immunization, 2d ed., ed. J. Andrus and C. de Quadros (Washington: PAHO Press, 2006), 114-126.
4. J. Andrus et al., "Accelerating Policy, Deployment, and Access to New and Underutilized Vaccines in Developing Countries," Harvard Health Policy Review 7, no. 2 (2006): 91-101.
5. Pan American Health Organization, "Immunization in the Americas: 2005 Summary - Morbidity," http://www.paho.org/English/AD/FCH/IM/ IMBrochure_2005.pdf (accessed 4 December 2007);
6. and PAHO, "PAHO EPI Indicator Tables: 1990-2004" (Washington: PAHO, 2005).
7. Bank of Social Statistics and Indicators (BADEINSO), "Millennium Indicators Database, Child Mortality Rates 1990, 1995, 2000, 2003" (Santiago, Chile: Economic Commission for Latin America and the Caribbean, 2005)
8. World Health Organization Statistical Information System (WHOSIS), "Original Global Burden of Disease (GBD) Estimates: Deaths by Age, Sex, and Cause for the Year 2002, WHO Region - AMRO," http://www.who.int/ healthinfo/gbdwhoregionmortality20020rig.xls (accessed 1 September 2006).
9. H. Peltola, "Haemophilus influenzae Type b Disease and Vaccination in Latin America and the Caribbean," Pediatric Infectious Disease Journal 16, no. 8 (1997): 780-787.
10. C. de Quadros et al., "Measles Eradication: Experience in the Americas," Morbidity and Mortality Weekly Report 48, Supp. 1 (1999): 57-64;
11. and WHO, Global Burden of Disease Estimates: 1990 (Geneva: WHO, 1993), 457.
12. PAHO, "Immunization in the Americas."
13. PAHO, "PAHO EPI Indicator Tables."
14. C.J.L. Murray and A.D. Lopez, Global Health Statistics (Boston: Harvard University Press, 1996), 282;
15. and WHO, Global Burden, 457.
16. PAHO, "Immunization in the Americas";
17. and WHO, "Estimated Annual Incidence ('000s) for Selected Causes: By Sex, Age, and WHO Subregion, 2002," AMRO, Row 19, Column F: Tetanus, http://www.who.int/healthinfo/statistics/gbdwhoregionincidence2002.xls (accessed 12 September 2006).
18. PAHO, "EPI Indicator Tables"; and WHO, Global Burden, 457.
19. PAHO, "Immunization in the Americas";
20. and WHO, "Estimates: Deaths for 2002, WHO Region," AMRO, Row 18, Code U012: Pertussis.
21. Peltola, "Haemophilus influenzae Type b Disease."
22. PAHO, "Immunization in the Americas."
23. L. Wolfson and P. Lydon, "Methodology for Estimating Baseline and Future Levels of Costing (and Impact) for the Global Immunization Vision and Strategy 2005-2015," Draft 1.1 (Geneva: WHO, 2005).
24. Andrus et al., "Introduction."
25. GAVI Alliance, Proposal for GAVI to Invest in Health Systems Strengthening (HSS) Support, 10 November 2005, http://www.vaccinealliance. org/resources/17brd_6a_HSS_IC_6Dec2005.pdf (accessed 12 September 2006);
26. and Global Fund, "The Global Fund to Collaborate with European Commission for Technical Assistance to Developing Country Health Systems," Press Release, 25 October 2004, http://www.theglobalfund.org/en/media_center/ press/pr_041025.asp (accessed 12 September 2006).
27. A. Schuchat, "Increasing Vaccine-Specific Coverage Rates among Pre-School Aged Children," Presentation at the 2005 National Immunization Conference, Atlanta, Georgia, http://cdc.confex.com/cdc/viewHandout.cgi? uploadid=967 (accessed 1 September 2006).
28. J. Brotherton et al., "Vaccine Preventable Diseases and Vaccination Coverage in Australia, 2001 to 2002," Communicable Diseases Intelligence 28, no. 2 Supp. (2004): vii-S116.
29. S. Lister et al., "Immunisation Coverage in Australian Children: A Systematic Review 1990-1998," Communicable Diseases Intelligence 23, no. 6 (1999): 145-170.
30. M. Guérin and C. Roure, "Immunisation Coverage in the European Union," Eurosurveillance 2, no. 1 (1997): 2-4.
31. Institute of Medicine, Immunization Safety Review: Vaccines and Autism (Washington: National Academies Press, 2004);
32. and WHO, "Thiomersal and Vaccines," 14 July 2006, http://www.who.int/vaccine_safety/topics/thiomersal/en (accessed 1 September 2006).
33. PAHO, "Update on Thimerosal and Autism," Immunization Newsletter (October 2005).
34. BADEINSO, "Millennium Indicators Database."
35. L. Brenzel et al., "Vaccine Preventable Diseases," in Disease Control Priorities in Developing Countries, 2d ed., ed. D. Jamison et al. (Oxford, England, and Washington: Oxford University Press and World Bank, 2006), 398.
36. D. Bloom et al., "The Value of Vaccination," World Economics 6, no. 3 (2005): 15-39.
37. G. Jones et al., "How Many Child Deaths Can We Prevent This Year?" Lancet 362, no. 9377 (2003): 65-71;
38. and L.P. Freedman et al., "Transforming Health Systems to Improve the Lives of Women and Children," Lancet 365, no. 9463 (2005): 997-1000.